Vascular Imaging Articles & Analysis
8 news found
His main areas of research are imaging of abdominal organs and cardio-vascular diseases, molecular imaging and population imaging. ...
ByFluidda
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular ...
ByRobocath
The update to Inscopix’s flagship product, the nVue™ System, now enables longitudinal dual color imaging and analysis of neural activity and blood flow in freely-behaving subjects. ...
Imaging of the pulmonary vasculature is crucial for our understanding of the short- and long-term consequences of COVID-19 Prof. William Li, president and medical director of the Angiogenesis Foundation, explains during an interview in Fluidda Magazine #2. Angiogenesis and vascular imaging form a very pressing issue to emerge from this pandemic. ...
ByFluidda
Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. The division will include several cutting-edge technologies, innovative vascular and cardiovascular products to provide clinicians with procedural and imaging solutions ...
First employed clinically overseas in October 2019, IOPS™ offers an alternative to the heavy dependence on 2-D fluoroscopic X-ray imaging in minimally-invasive vascular surgery. Cleared as an adjunct to fluoroscopy for descending aortic interventions, IOPS™ provides interactive, color, 3-D visualization for precise surgical navigation of guidewires ...
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. ...
These permanent materials may cause chronic inflammatory reaction in the treated area as well as restrict vascular access for future treatment. University of Minnesota researchers have developed embolic agents that can be absorbed by the body after the therapeutic treatment has been obtained. ...